Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting

References

• PardridgeWMWhy is the global CNS pharmaceutical market so under-penetrated?Drug Discov Today200271 5 711790589
   PubMed Web of Science ®Google Scholar
• NuttDGoodwinGECNP summit on the future of CNS drug research in Europe 2011: report prepared for ECNPEur Neuropsychopharmacol2011217 495 49921684455
   PubMedGoogle Scholar
• TurnerRCDodsonSCRosenCLHuberJDThe science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future successJ Neurosurg20131185 1072 108523331000
   PubMed Web of Science ®Google Scholar
• GargTBhandariSRathGGoyalAKCurrent strategies for targeted delivery of bioactive drug molecules in the treatment of brain tumorJ Drug Target20152310 865 88725835469
   PubMed Web of Science ®Google Scholar
• IqbalKLiuFGongmCTau and neurodegenerative disease: the story so farNat Rev Neurol2016121 15 2726635213
   PubMed Web of Science ®Google Scholar
• PalmerAMAlavijehMSTranslational CNS medicines researchDrug Discov Today20121719–20 1068 107822580061
   PubMed Web of Science ®Google Scholar
• PangalosMNSchechterLEHurkoODrug development for CNS disorders: strategies for balancing risk and reducing attritionNat Rev Drug Discov200767 521 53217599084
   PubMed Web of Science ®Google Scholar
• GaudinAAndrieuxKCouvreurPNanomedicines and stroke: toward translational researchJ Drug Deliv Sci Tec201530B 278 299
   Web of Science ®Google Scholar
• BernackiJDobrowolskaANierwinskaKMaleckiAPhysiology and pharmacological role of the blood-brain barrierPharmacol Rep2008605 600 62219066407
   PubMed Web of Science ®Google Scholar
• CardosoFLBritesDBritoMALooking at the blood-brain barrier: molecular anatomy and possible investigation approachesBrain Res Rev2010642 328 36320685221
   PubMed Web of Science ®Google Scholar
• AbbottNJPatabendigeAADolmanDEYusofSRBegleyDJStructure and function of the blood–brain barrierNeurobiol Dis2010371 13 2519664713
   PubMed Web of Science ®Google Scholar
• PardridgeWMDrug transport across the blood-brain barrierJ Cereb Blood Flow Metab20123211 1959 197222929442
   PubMed Web of Science ®Google Scholar
• AguzziABarresBBennettMLMicroglia: scapegoat, saboteur, or something else?Science20133396116 156 16123307732
   PubMed Web of Science ®Google Scholar
• DanemanRRescignoMThe gut immune barrier and the blood-brain barrier: are they so different?Immunity2009315 722 73519836264
   PubMed Web of Science ®Google Scholar
• BanksWABlood-brain barrier as a regulatory interfaceForum Nutr201063 102 11019955778
   PubMedGoogle Scholar
• ChenYDalwadiGBensonHADrug delivery across the blood-brain barrierCurr Drug Deliv200414 361 37616305398
   PubMedGoogle Scholar
• PardridgeWMMolecular biology of the blood–brain barrierMol Biotechnol2005301 57 7015805577
   PubMed Web of Science ®Google Scholar
• AbbottNJRonnbackLHanssonEAstrocyte-endothelial interactions at the blood–brain barrierNat Rev Neurosci200671 41 5316371949
   PubMed Web of Science ®Google Scholar
• de VriesHEKooijGFrenkelDGeorgopoulosSMonsonegoAJanigroDInflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical diseaseEpilepsia2012536 45 52
   Web of Science ®Google Scholar
• ObermeierBDanemanRRansohoffRMDevelopment, maintenance, and disruption of the blood–brain barrierNat Med20131912 1584 159624309662
   PubMed Web of Science ®Google Scholar
• van TellingendOYetkin-ArikcBde GooijerdMCWesselingePWurdingerTde VriesHEOvercoming the blood–brain tumor barrier for effective glioblastoma treatmentDrug Resist Updat201519 1 1225791797
   PubMed Web of Science ®Google Scholar
• VlieghePKhrestchatiskyMMedicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and deliveryMed Res Rev2013333 457 51622434495
   PubMed Web of Science ®Google Scholar
• Aparicio-BlancoJMartín-SabrosoCTorres-SuarezAIIn vitro screening of nanomedicines through the blood brain barrier: a critical reviewBiomaterials2016103 229 25527392291
   PubMed Web of Science ®Google Scholar
• FisherMFeuersteinGHowellsDWUpdate of the stroke therapy academic industry roundtable preclinical recommendationsStroke2009406 2244 225019246690
   PubMed Web of Science ®Google Scholar
• CaliasPBanksWABegleyDScarpaMDicksonPIntrathecal delivery of protein therapeutics to the brain: a critical reassessmentPharmacol Ther20141442 114 12224854599
   PubMed Web of Science ®Google Scholar
• CeliaCCoscoDPaolinoDFrestaMNanoparticulate devices for brain drug deliveryMed Res Rev2011315 716 75620162690
   PubMed Web of Science ®Google Scholar
• StojanovKZuhornISDierckxRAde VriesEFImaging of cells and nanoparticles: implications for drug delivery to the brainPharm Res20122912 32313 32340
   Web of Science ®Google Scholar
• ChenYLiuLModern methods for delivery of drugs across the blood–brain barrierAdv Drug Deliv Rev2012647 640 66522154620
   PubMed Web of Science ®Google Scholar
• HershDSWadajkarASRobertsNBEvolving drug delivery strategies to overcome the blood brain barrierCurr Pharm Des2016229 1177 119326685681
   PubMed Web of Science ®Google Scholar
• BanksWAFrom blood-brain barrier to blood-brain interface: new opportunities for CNS drug deliveryNat Rev Drug Discov2016154 275 29226794270
   PubMed Web of Science ®Google Scholar
• SinghDKapahiHRashidMPrakashAMajeedABMishraNRecent prospective of surface engineered nanoparticles in the management of neurodegenerative disordersArtif Cells Nanomed Biotechnol2016443 780 79126107112
   PubMed Web of Science ®Google Scholar
• IngallinaCRinaldiFBogniANiosomal approach to brain delivery: development, characterization and in vitro toxicological studiesInt J Pharm20165112 969 98227498282
   PubMed Web of Science ®Google Scholar
• HerveFGhineaNScherrmannJMCNS delivery via adsorptive transcytosisAAPS J2008103 455 47218726697
   PubMed Web of Science ®Google Scholar
• BhaskarSTianFStoegerTMultifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingPart Fibre Toxicol20107 320199661
   PubMed Web of Science ®Google Scholar
• IllumLNasal drug delivery – recent developments and future prospectsJ Control Release20121612 254 26322300620
   PubMed Web of Science ®Google Scholar
• HansenKKimGDesaiKGFeasibility investigation of cellulose polymers for mucoadhesive nasal drug delivery applicationsMol Pharm2015128 2732 274126097994
   PubMed Web of Science ®Google Scholar
• KumarAPandeyANJainSKNasal nanotechnology: revolution for efficient therapeutics deliveryDrug Deliv2016233 671 683
   Web of Science ®Google Scholar
• FreyWHNeurologic Agents for Nasal Administration to the BrainEmeryville, CAChiron Corporation1991
   Google Scholar
• ZhuJJiangYXuGLiuXIntranasal administration: a potential solution for cross-BBB delivering neurotrophic factorsHistol Histopathol201227 537 54822419018
   PubMed Web of Science ®Google Scholar
• JiangYZhuJXuGLiuXIntranasal delivery of stem cells to the brainExpert Opin Drug Deliv201185 623 63221417782
   PubMed Web of Science ®Google Scholar
• LochheadJJThorneRGIntranasal delivery of biologics to the central nervous systemAdv Drug Deliv Rev2012647 614 62822119441
   PubMed Web of Science ®Google Scholar
• MarianecciCRinaldiFHaniehPNPaolinoDDi MarzioLCarafaMNose to brain delivery: new trends in amphiphile-based “soft” nanocarriersCurr Pharm Des20152136 5225 523226412357
   PubMed Web of Science ®Google Scholar
• ChenMWuBYeXAssociation between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemic strokeJ Clin Neurosci20111811 1454 145721917464
   PubMed Web of Science ®Google Scholar
• PiresAFortunaAAlvesGFalcãoAIntranasal drug delivery: how, why and what for?J Pharm Pharm Sci2009123 288 31120067706
   PubMed Web of Science ®Google Scholar
• JiangYLiYLiuXIntranasal delivery: circumventing the iron curtain to treat neurological disordersExpert Opin Drug Deliv20151211 1717 172526206202
   PubMed Web of Science ®Google Scholar
• BornJLangeTKernWMcGregorGPBickelUFehmHLSniffing neuropeptides: a transnasal approach to the human brainNat Neurosci200256 514 51611992114
   PubMed Web of Science ®Google Scholar
• MerkusPGuchelaarHJBoschDAMerkusFWDirect access of drugs to the human brain after intranasal drug administration?Neurology20036010 1669 167112771261
   PubMed Web of Science ®Google Scholar
• MerkusFWvan den BergMPCan nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theoryDrugs R D200783 133 14417472409
   PubMedGoogle Scholar
• BleierBSWangEWVandergriftWASchlosserRJMucocele rate following endoscopic skull base reconstruction using vascularized pedicled flapsAm J Rhinol Allergy2011253 186 18721679531
   PubMed Web of Science ®Google Scholar
• SuhJDRamakrishnanVRDeCondeASNasal floor free mucosal graft for skull base reconstruction and cerebrospinal fluid leak repairAnn Otol Rhinol Laryngol20121212 91 9522397216
   PubMed Web of Science ®Google Scholar
• TingJOMetsonRFree graft techniques in skull base reconstructionAdv Otorhinolaryngol2013741 33 4123257550
   PubMedGoogle Scholar
• Bernal-SprekelsenMAlobidIMullolJTrobatFToma´s-Barbera´nMClosure of cerebrospinal fluid leaks prevents ascending bacterial meningitisRhinology2005434 277 28116405272
   PubMed Web of Science ®Google Scholar
• MiyakeMMBleierBSThe blood-brain barrier and nasal drug delivery to the central nervous systemAm J Rhin Allergy2015292 124 127
   PubMed Web of Science ®Google Scholar
• BleierBSKohmanREFeldmanRERamanlalSHanXPermeabilization of the blood-brain barrier via mucosal engrafting: implications for drug delivery to the brainPLoS One201384 e61694.1 723637885
   PubMed Web of Science ®Google Scholar
• BleierBSPalmerJNSparanoAMCohenNALaser-assisted cerebro-spinal fluid leak repair: an animal model to test feasibilityOtolaryngol Head Neck Surg2007137 810 81417967651
   PubMed Web of Science ®Google Scholar
• BleierBSKohmanREGuerraKHeterotopic mucosal grafting enables the delivery of therapeutic neuropeptides across the blood brain barrierNeurosurgery2016783 448 45726352099
   PubMed Web of Science ®Google Scholar
• MerkusFVerhoefJSchipperNMarttinENasal mucociliary clearance as a factor in nasal drug deliveryAdv Drug Deliv Rev1998291–2 13 3810837578
   PubMed Web of Science ®Google Scholar
• FullerMMeiklePJHopwoodJJEpidemiology of lysosomal storage diseases: an overviewMehtaABeckMSunder-PlassmannGFabry Disease: Perspectives from 5 Years of FOSOxford, UKOxford PharmaGenesis2006
   Google Scholar
• ParentiGAndriaGBallabioALysosomal storage diseases: from pathophysiology to therapyAnnu Rev Med201566 471 48625587658
   PubMed Web of Science ®Google Scholar
• MehtaAWinchesterBLysosomal Storage Disorders: A Practical GuideChichester, UKWiley2012
   Google Scholar
• CarveyPMHendeyBMonahanAJThe blood-brain barrier in neurodegenerative disease: a rhetorical perspectiveJ Neurochem20091112 291 31419659460
   PubMed Web of Science ®Google Scholar
• PalmerAMThe role of the blood brain barrier in neurodegenerative disorders and their treatmentJ Alzheimers Dis2011244 643 65621460432
   PubMed Web of Science ®Google Scholar
• CoxTMInnovative treatments for lysosomal diseasesBest Pract Res Clin Endocrinol Metab2015292 275 31125987179
   PubMed Web of Science ®Google Scholar
• BartonNWBradyRODambrosiaJMReplacement therapy for inherited enzyme deficiency macrophage-targeted glucocerebrosidase for Gaucher’s diseaseN Engl J Med199132421 1464 14702023606
   PubMed Web of Science ®Google Scholar
• BartonNWFurbishFSMurrayGJGarfieldMBradyROTherapeutic response to intravenous infusions of glu- cocerebrosidase in a patient with Gaucher diseaseProc Natl Acad Sci U S A1990875 1913 19162308952
   PubMed Web of Science ®Google Scholar
• EngCMGuffonNWilcoxWRSafety and efficacy of recombinant human α-galactosidase A replacement therapy in Fabry’s diseaseN Engl J Med20013451 9 1611439963
   PubMed Web of Science ®Google Scholar
• SchiffmannRKoppJBAustinHA3rdEnzyme replacement therapy in Fabry disease: a randomized controlled trialJAMA2001285 2743 274911386930
   PubMed Web of Science ®Google Scholar
• Van den HoutHReuserAJVultoAGLoonenMCCromme-DijkhuisAVan der PloegATRecombinant human α-glucosidase from rabbit milk in Pompe patientsLancet20003569227 397 39810972374
   PubMed Web of Science ®Google Scholar
• KakkisEDMuenzerJTillerGEEnzyme-replacement therapy in mucopolysaccharidosis IN Engl J Med20013443 182 18811172140
   PubMed Web of Science ®Google Scholar
• MuenzerJWraithJEBeckMA phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)Genet Med200688 465 47316912578
   PubMed Web of Science ®Google Scholar
• HarmatzPGiuglianiRSchwartzIEnzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyJ Pediatr2006148 533 53916647419
   PubMed Web of Science ®Google Scholar
• GrubbJHVoglerCLevyBGalvinNTanYSlyWSChemically modified β-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VIIProc Natl Acad Sci U S A2008105 2616 262118268347
   PubMed Web of Science ®Google Scholar
• HuynhHTGrubbJHVoglerCSlyWSBiochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VIIProc Natl Acad Sci U S A2012109 17022 1702723027951
   PubMed Web of Science ®Google Scholar
• BoadoRJZhangYZhangYXiaCFWangYPardridgeWMGenetic engineering, expression, and activity of achimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humansBioconjug Chem201219 731 739
   Web of Science ®Google Scholar
• OsbornMJMcElmurryRTPeacockBTolarJBlazarBRTargeting of the CNS in MPS-IH using a nonviral transferrin-α-L-iduronidase fusion gene productMol Ther2008168 1459 146618523448
   PubMed Web of Science ®Google Scholar
• ZhouQHBoadoRJLuJZHuiEKPardridgeWMBrain-penetrating IgG-iduronate 2-sulfatase fusion protein for the mouseDrug Metab Dispos2012402 329 33522065691
   PubMed Web of Science ®Google Scholar
• BockenhoffACramerSWoltePComparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase AJ Neurosci2014349 3122 312924573272
   PubMed Web of Science ®Google Scholar
• MengYSoharISleatDEEffective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brainMol Ther2014223 547 55324394185
   PubMed Web of Science ®Google Scholar
• KakkisEMcEnteeMVoglerCIntrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS IMol Genet Metab2004831–2 163 17415464431
   PubMed Web of Science ®Google Scholar
• DicksonPMcEnteeMVoglerCIntrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluidMol Genet Metab2007911 61 6817321776
   PubMed Web of Science ®Google Scholar
• AuclairDFinnieJWhiteJRepeated intrathecal injections of recombinant human 4-sulfatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimenMol Genet Metab201099 132 14119896877
   PubMed Web of Science ®Google Scholar
• AuclairDFinnieJWalkleySUIntrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI catsPediatr Res201271 39 4522289849
   PubMed Web of Science ®Google Scholar
• BoboRHLaskeDWAkbasakAMorrisonPFDedrickRLOldfieldEHConvection-enhanced delivery of macromolecules in the brainProc Natl Acad Sci U S A1994916 2076 20808134351
   PubMed Web of Science ®Google Scholar
• KrollRAPagelMAMuldoonLLRoman-GoldsteinSNeuweltEAIncreasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factorNeurosurgery1996384 746 7528692395
   PubMed Web of Science ®Google Scholar
• SiegalTRubinsteinRBoksteinFIn vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humansJ Neurosurg2000924 599 60510761648
   PubMed Web of Science ®Google Scholar
• CostantinoLBoraschiDIs there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?Drug Discov Today2012177 367 37822094246
   PubMed Web of Science ®Google Scholar
• SpencerBJVermaIMTargeted delivery of proteins across the blood–brain barrierProc Natl Acad Sci U S A200710418 7594 759917463083
   PubMed Web of Science ®Google Scholar
• PatelTZhouJPiepmeierJMSaltzmanWMPolymeric nanoparticles for drug delivery to the central nervous systemAdv Drug Deliv Rev2012647 701 70522210134
   PubMed Web of Science ®Google Scholar
• OnoderaHTakadaGTadaKDesnickRJMicroautoradiographic study on the tissue localization of liposome-entrapped or unentrapped 3H-labeled beta-galactosidase injected into ratsTohoku J Exp Med19831401 1 136408762
   PubMed Web of Science ®Google Scholar
• ChuZSunYKuanCYGrabowskiGAQiXSaposin C: neuronal effect and CNS delivery by liposomesAnn N Y Acad Sci20051053 237 24616179529
   PubMed Web of Science ®Google Scholar
• ThekkedathRKoshkaryevATorchilinVPLysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher’s cells in vitroNanomedicine201387 1055 106523199221
   PubMed Web of Science ®Google Scholar
• TosiGBortotBRuoziBPotential use of polymeric nanoparticles for drug delivery across the blood-brain barrierCurr Med Chem20132017 2212 222523458620
   PubMed Web of Science ®Google Scholar
• TosiGRuoziBBellettiDBrain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodentsNanomedicine201389 1373 138323565661
   PubMed Web of Science ®Google Scholar
• TosiGVilellaAChhabraRInsight on the fate of CNS-targeted nanoparticles. Part II: intercellular neuronal cell-to-cell transportJ Control Release2014177 96 10724417968
   PubMed Web of Science ®Google Scholar
• VilellaATosiGGrabruckerAMInsight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell- specific uptake and distributionJ Control Release2014174 195 20124316476
   PubMed Web of Science ®Google Scholar
• PardridgeWMDrug and gene targeting to the brain with molecular Trojan horsesNat Rev Drug Discov200212 131 13912120094
   PubMed Web of Science ®Google Scholar
• TomaninRZanettiAZaccariottoED’AvanzoFBellettatoCMScarpaMGene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseasesActa Paediatr20121017 692 70122428546
   PubMed Web of Science ®Google Scholar
• PrinzMPrillerJSisodiaSSRansohoffRMHeterogeneity of CNS myeloid cells and their roles in neurodegenerationNat Neurosci20111410 1227 123521952260
   PubMed Web of Science ®Google Scholar
• VisigalliIDelaiSPolitiLSGene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse modelBlood201011624 5130 513920847202
   PubMed Web of Science ®Google Scholar
• CassanoMFelippuAEndoscopic treatment of cerebrospinal fluid leaks with the use of lower turbinate grafts: a retrospective review of 125 casesRhinology2009474 362 36819936359
   PubMed Web of Science ®Google Scholar
• KimpleAJLeightWDWhelessSAZanationAMReducing nasal morbidity after skull base reconstruction with the nasoseptal flap: free middle turbinate mucosal graftsLaryngoscope20121229 1920 192422926937
   PubMed Web of Science ®Google Scholar
• GillSSPatelNKHottonGRDirect brain infusion of glial cell line-derived neurotrophic factor in Parkinson diseaseNat Med200395 589 59512669033
   PubMed Web of Science ®Google Scholar